KCS21 Antibody

Shipped with Ice Packs
In Stock

Description

KirChannel Overview

Kir2.1 (encoded by KCNJ2) is an inward rectifier potassium channel critical for maintaining resting membrane potential in excitable tissues. It is expressed in cardiac muscle, skeletal muscle, kidney, and brain . Dysfunction in Kir2.1 is linked to:

  • Andersen-Tawil Syndrome (Long QT Syndrome Type 7)

  • Short QT Syndrome 3

  • Familial Atrial Fibrillation 9 .

Cardiac Electrophysiology

  • Role in Arrhythmias: Kir2.1 interacts with Nav1.5 sodium channels, forming a macromolecular complex that regulates cardiac excitability. Disruption of this interaction predisposes to atrial fibrillation .

  • Pathogenic Mutations: Anti-Kir2.1 antibodies have been used to study KCNJ2 mutations in Andersen-Tawil syndrome, revealing reduced current density and prolonged action potential duration .

Neurological Studies

  • Striatal Function: Kir2.1 regulates dendritic morphology of medium spiny neurons in the striatum via D2 dopamine receptors, impacting motor control .

Table 1: Selected Studies with Anti-Kir2.1 Antibodies

ApplicationStudyFindingsCitation
ImmunocytochemistryCheng et al. (2018)Kir2.1 colocalizes with Smoothened in cardiomyocytes, modulating K+ currents
Western BlotHegyi et al. (2020)Hyperglycemia alters Kir2.1 O-GlcNAcylation, affecting cardiac K+ currents
ImmunoprecipitationPonce-Balbuena et al. (2018)Kir2.1 and Nav1.5 traffic jointly to the sarcolemma, influencing excitability

Disease Associations and Therapeutic Potential

  • McLeod Syndrome: Loss of Kx protein (linked to Kir2.1) causes acanthocytosis and neuromuscular deficits .

  • Therapeutic Targets: Antibodies against Kir2.1 are tools for studying channelopathies but are not yet approved for clinical use .

Comparative Analysis of KirAntibodies

ParameterN112B/14 (75-210)MAB9548
Host SpeciesMouseRabbit
ApplicationsICC, IHC, WBWB, ICC
Cross-ReactivityNone with Kir2.2/2.3Not specified
Key PublicationCheng et al. (2018)Jimenez-Vazquez et al. (2022)

Future Directions

  • Gene Therapy: KCNJ2 rescue in induced pluripotent stem cell-derived cardiomyocytes shows antiarrhythmic potential .

  • Structural Studies: Cryo-EM and AlphaFold predictions could refine epitope mapping for antibody development .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
KCS21; KCS20; At5g49070; K20J1.4; Probable 3-ketoacyl-CoA synthase 21; KCS-21; Very long-chain fatty acid condensing enzyme 21; VLCFA condensing enzyme 21
Target Names
KCS21
Uniprot No.

Target Background

Database Links

KEGG: ath:AT5G49070

STRING: 3702.AT5G49070.1

UniGene: At.65660

Protein Families
Chalcone/stilbene synthases family
Subcellular Location
Membrane; Single-pass membrane protein.
Tissue Specificity
Expressed in flowers.

Q&A

Basic Research Questions

  • What is KCS21 and what experimental applications is the KCS21 antibody suitable for?

KCS21 (3-ketoacyl-CoA synthase 21) is a protein encoded by the KCS21 gene (AT5G49070) in Arabidopsis thaliana, involved in very-long-chain fatty acid biosynthesis pathways. The commercially available KCS21 antibody is typically a rabbit polyclonal antibody raised against recombinant Arabidopsis thaliana KCS21 protein .

The antibody is validated for:

  • ELISA (Enzyme-Linked Immunosorbent Assay)

  • Western Blotting (for identification of antigen)

Key experimental considerations:

  • Species reactivity: Plant (primarily Arabidopsis thaliana)

  • Storage requirements: -20°C or -80°C for optimal stability

  • Format: Typically supplied as protein A/G purified IgG

  • What controls should I include when using KCS21 antibody for immunofluorescence experiments?

When designing immunofluorescence experiments with KCS21 antibody, include these essential controls:

Positive controls:

  • Cell/tissue types known to express KCS21 (based on literature)

  • Samples from wild-type Arabidopsis as baseline expression controls

Negative controls:

  • Secondary-only control (omit primary KCS21 antibody) to assess non-specific binding

  • PBS-only treatment to evaluate autofluorescence in plant tissues

  • KCS21 knockout/knockdown samples (if available) to confirm specificity14

Endogenous controls:

  • Include antibodies against constitutively expressed proteins to assess tissue integrity

  • Check for morphological indicators of cell/tissue damage that might affect results14

For multi-fluorophore experiments, single-color controls are essential to:

  • Detect fluorophore bleed-through into other channels

  • Set up spectral unmixing parameters

  • Determine maximum exposure settings to avoid non-specific signal14

  • How can I validate the specificity of KCS21 antibody for my experimental system?

Rigorous validation is critical before using any antibody in research. For KCS21 antibody:

Expression validation:

  • Compare antibody reactivity in tissues with known high vs. low KCS21 expression

  • Verify signal reduction in KCS21 knockdown/knockout plants

  • Correlate protein detection with transcript levels from RT-PCR/RNA-seq data

Molecular weight confirmation:

  • Ensure detected band matches predicted molecular weight of KCS21

  • Verify absence of non-specific bands at unexpected molecular weights

Peptide competition assay:

  • Pre-incubate KCS21 antibody with immunizing peptide/protein

  • Signal should be significantly reduced or eliminated

Cross-reactivity assessment:

  • Test specificity using related KCS family members (e.g., KCS20)

  • Evaluate recognition pattern across different plant species

Remember that "the quality of commercially available antibodies and validation information varies greatly," with failure rates among vendors ranging from 0-100% . Always generate your own validation data regardless of commercial claims.

Advanced Research Questions

  • What techniques can enhance detection sensitivity when using KCS21 antibody for low-abundance targets?

When working with low-abundance KCS21 protein:

Sample preparation optimization:

  • Enrich membrane fractions where KCS21 is likely to be concentrated

  • Use detergent combinations optimized for membrane protein extraction

  • Consider phosphatase/protease inhibitors to prevent target degradation

Signal amplification strategies:

  • Implement tyramide signal amplification (TSA) for immunofluorescence

  • Utilize more sensitive detection systems (e.g., ECL Prime vs. standard ECL)

  • Try biotinylated secondary antibodies with streptavidin-HRP for Western blots

Protocol modifications:

  • Increase antibody incubation time (overnight at 4°C)

  • Optimize blocking solutions to reduce background while preserving specific signal

  • Consider antigen retrieval methods for fixed plant tissues

Enhanced imaging approaches:

  • Use confocal microscopy with spectral unmixing to separate signal from autofluorescence

  • Apply deconvolution algorithms to improve signal-to-noise ratio

  • Consider super-resolution microscopy for precise subcellular localization14

  • How do I troubleshoot non-specific binding issues with KCS21 antibody in plant tissues?

Non-specific binding is a common challenge with plant antibodies. Address it systematically:

Binding pattern analysis:

  • Compare pattern with known KCS21 localization literature

  • Verify if signal appears in tissues not expected to express KCS21

  • Examine nuclear or other non-target compartment staining that may indicate non-specificity

Optimization strategies:

  • Test blocking agents specifically designed for plant tissues (BSA, non-fat milk, normal serum)

  • Try different detergents in wash buffers (Tween-20, Triton X-100) to reduce hydrophobic interactions

  • Adjust antibody concentration through systematic titration experiments

  • Modify fixation protocols that may contribute to artificial epitope exposure

Sample-specific considerations:

  • Plant tissues often contain compounds that interfere with antibody binding

  • Pre-absorb antibody with tissue powder from negative control samples

  • Use plant-specific tissue clearing methods to reduce autofluorescence

  • What are the methodological differences when using KCS21 antibody across different plant species?

When expanding KCS21 antibody use to different plant species:

Cross-reactivity assessment:

  • Perform sequence alignment of KCS21 orthologs to predict cross-reactivity

  • Test antibody on a panel of species with varying evolutionary distance from Arabidopsis

  • Verify signal specificity in each new species using appropriate controls

Protocol adaptations:

  • Optimize fixation methods for different plant tissue types

  • Adjust extraction buffers to account for species-specific biochemical differences

  • Consider species-specific cell wall composition when designing permeabilization steps

Comparative analysis considerations:

  • Standardize protein loading using conserved housekeeping proteins

  • Account for potential differences in subcellular localization across species

  • Document epitope conservation when interpreting cross-species signal variation

SpeciesHomology to A. thaliana KCS21Expected Cross-ReactivityRecommended Protocol Modifications
Brassicaceae familyHigh (>80%)Likely strongStandard protocol
Other dicotsModerate (60-80%)VariableIncreased antibody concentration, extended incubation
MonocotsLower (40-60%)LimitedMay require epitope-specific validation
GymnospermsVery low (<40%)UnlikelyNot recommended without extensive validation
  • How can I implement KCS21 antibody in co-localization studies with other plant cellular markers?

For effective co-localization studies:

Experimental design considerations:

  • Select marker antibodies raised in different host species than KCS21 antibody (rabbit)

  • Choose fluorophores with minimal spectral overlap

  • Include appropriate single-stain controls to detect bleed-through

Technical implementation:

  • Sequential staining may be required if antibodies are from the same species

  • Use Zenon labeling or other direct conjugation methods for same-species antibodies

  • Apply structured illumination or confocal microscopy for precise co-localization assessment

Quantitative analysis approaches:

  • Calculate Pearson's correlation coefficient or Manders' overlap coefficient

  • Use JACoP or similar plugins in ImageJ for quantitative co-localization analysis

  • Apply object-based co-localization for more specific spatial relationship determination

Expected co-localization patterns:

  • KCS21 likely co-localizes with endoplasmic reticulum markers

  • Partial co-localization with Golgi or plasma membrane markers may be observed

  • Correlate findings with published subcellular localization databases 14

  • What are the critical factors for reproducible quantitative Western blotting using KCS21 antibody?

For quantitative Western blotting:

Sample preparation standardization:

  • Standardize tissue harvesting conditions (time of day, plant age, growth conditions)

  • Use consistent protein extraction method optimized for membrane proteins

  • Determine protein concentration using methods less affected by plant compounds (e.g., BCA)

Loading and transfer optimization:

  • Validate linear range of detection for KCS21 in your system

  • Include multiple technical replicates for statistical validation

  • Use internal loading controls appropriate for plant samples (e.g., actin, GAPDH)

Signal acquisition:

  • Utilize digital imaging systems rather than film for wider linear range

  • Capture multiple exposure times to ensure measurements within linear range

  • Avoid saturated pixels which invalidate quantitation

Data analysis:

  • Normalize to appropriate loading controls

  • Apply statistical tests suitable for your experimental design

  • Report biological and technical variability transparently

Quantification ParameterRecommended ApproachCommon Pitfalls
Loading control selectionUse constitutively expressed proteins unaffected by treatmentAssuming all housekeeping proteins are stable across conditions
Signal normalizationNormalize to total protein (Ponceau) and specific loading controlOver-reliance on single normalization method
Statistical analysisUse sufficient biological replicates (minimum n=3)Treating technical replicates as biological replicates
Data presentationShow representative blots alongside quantificationShowing only quantification without original blots
  • How can I modify protocols to use KCS21 antibody on fixed plant tissue sections?

Adapting protocols for fixed tissue immunohistochemistry:

Fixation optimization:

  • Test different fixatives: 4% paraformaldehyde, Carnoy's, or glutaraldehyde combinations

  • Optimize fixation time to balance tissue preservation with epitope accessibility

  • Consider vacuum infiltration to ensure fixative penetration in plant tissues

Antigen retrieval methods:

  • Heat-induced epitope retrieval (citrate buffer, pH 6.0)

  • Enzymatic antigen retrieval (protease K, trypsin)

  • Combined approaches for improved epitope accessibility

Tissue-specific adaptations:

  • For highly cutinized tissues, include pre-permeabilization steps

  • Adjust clearing protocols to reduce autofluorescence from chlorophyll or phenolic compounds

  • Consider vibratome sections for sensitive tissues where paraffin embedding affects antigenicity

Signal detection optimization:

  • Implement multi-step amplification systems for low-abundance targets

  • Use fluorophores with emission spectra distinct from plant autofluorescence

  • Consider chromogenic detection methods as alternatives when autofluorescence is problematic 14

  • How can I assess potential cross-reactivity of KCS21 antibody with other members of the KCS protein family?

Given the sequence similarity within the KCS family, comprehensive cross-reactivity assessment is essential:

Sequence-based prediction:

  • Perform multiple sequence alignment of all KCS family proteins

  • Identify regions of high homology that might lead to cross-reactivity

  • Compare the immunizing antigen sequence with other KCS proteins

Experimental validation:

  • Test antibody against recombinant proteins of closely related KCS family members

  • Use tissues with differential expression patterns of KCS family members

  • Examine tissues from knockout/knockdown lines of different KCS genes

Absorption experiments:

  • Pre-absorb antibody with recombinant related KCS proteins

  • Compare staining patterns before and after absorption

  • Quantify signal reduction to estimate degree of cross-reactivity

KCS Family MemberSequence Similarity to KCS21Potential Cross-ReactivityValidation Approach
KCS20Highest (>80%)Very likelyEssential to test with specific controls
KCS19, KCS22Moderate (60-80%)PossibleRecommended validation
Other KCS membersVariable (30-60%)Less likely but possibleTest if working in relevant tissues

"Whereas the presence of autoantibodies in cancer patients has been acknowledged, their diagnostic or therapeutic significance has yet to be established. This is due, at least in part, to the lack of robust screening techniques to detect and characterize such antibodies for further assessment" . Similar principles apply to research antibodies like KCS21, where robust validation techniques are crucial for meaningful data interpretation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.